Topper Copies

You are the Director of the National Bioethics Commission who is responsible for assessing the ethical feasibility and oversight of a nationwide gene sequencing program. The project named GeneFuture, aims to sequence the DNA of every newborn child and store it in a centralized national database. The objective is to identify genetic predispositions to serious diseases early in life, allowing for preventive treatment and personalized medicine. Over 100,000 babies have already been enrolled in the pilot phase of the program. The government claims that this move is a landmark step in public health advancement. However, collection of newborn genetic data raises significant ethical concerns, particularly around informed consent, which may not fully capture parents' understanding of the long-term risks involved. Once gathered, this sensitive data could be misused for purposes such as surveillance, insurance discrimination, or commercial marketing by third parties. Uncertainty over data ownership — whether it lies with the state, parents, or the individual as they mature — further complicates the issue. The involvement of private tech and pharmaceutical companies heightens fears of commercial exploitation, especially in the absence of clear mechanisms for individuals to withdraw consent or delete their genetic information upon reaching adulthood. (a) What are the ethical issues you perceive in the implementation of the GeneFuture program? (b) Identify the conflicting interests of different stakeholders in this case. (c) What guiding ethical principles would you recommend for implementation of this project? (Answer in 250 words)

Akansh Dhull, AIR 3, 2025

The issue highlights individual VS societal conflict around genome privacy. The larger idea is about long term consequences, both seen and unseen, which are also given for genome editing.

a) Ethical Issues in the case

1. Genetic privacy of individual 2. Uninformed consent is no consent, influences all three:

3. Issue of transparency, accountability in long run 4. Agency issue: who is owner of data 5. Limits to parens patriae: how much autonomy should individual surrender 6. Fear of corporate greed: commerce without morality 7. Procedural lapses: no way to delete data, timeline for data use 8. Treating individuals as 'instruments' not ends: Kantian ethics 9. Consequentialism, but utility for whom?

b) Different stakeholders

Conflicting Interests

1. Scientific community needs data for breakthrough but may make individual guinea pigs 2. Ethics of longtermism: impact on long term interest of children, what's in his best interest? 3. Who decides consent of new born? Parents are unaware 4. Government wants maximum benefit for maximum, but doesn't want disproportionate impact on few 5. Private Companies want such information to maximise profit, but may violate individual dignity

c) Guiding Principles in this project

1. Undertake long term risk assessment, prevent comprehensive mitigation plan 2. Involve all stakeholders in plan formulation: consensus only when occurred, not forced 3. Comprehensive disclosure to parents & no coercion 4. Undertake pilot project: evaluate impact and risks 5. Learn best practices from other countries 6. Envisage long term impact: envision future consequence, enable and provide enabling ecosystem, empower withdraw consent 7. Full transparency

8. Treat each case at merit: need only 10,000, so qualitative data collected, doctrine of minimum harm 9. Ethics of bad choices: every decision has some challenge. "The art of civil servant is knowing what to leave and what to stick." Equality, dignity, privacy, expression non negotiable, profits can wait 10. Create robust timeline, proactive disclosure, grievance redressal framework

While the policy has good ends, it should not be instrumentalist and balanced with good means. If privacy is sidestepped, it erodes democratic trust, creates risk of technofeudalism, neoslavery and autocratic surveillance state.